Study of G-CSF for diminished ovarian reserve in IVF
This study tests a medicine called G-CSF (given as an injection) to see if it helps improve egg quality and IVF success in women with a lower egg supply (diminished ovarian reserve). If you are between 35 and 44 and have been told your egg count is low but not too low, this might be worth exploring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 35 and 44 years old.
- You plan to have in vitro fertilization (IVF) treatment at the Center for Human Reproduction (CHR).
- Your blood tests show a certain level of 'day 3 FSH' (a hormone) below 10 IU/L.
- Your blood tests show a certain level of AMH (a hormone that reflects egg supply) above 1.2 ng/mL.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether platelet-rich plasma (PRP) can improve fertility outcomes in people with low egg reserve. It may help if you are in the right age range and have been diagnosed with diminished ovarian reserve or poor ovarian response.
This trial compares two hormone injection protocols to help women with low egg supply grow eggs and collect eggs for IVF. If you qualify, your embryos will be frozen first (“freeze-all”) and then transferred later as one frozen blastocyst.
This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.
This study tests whether a supplement called NMN can improve pregnancy outcomes for women with low ovarian reserve who are undergoing IVF or ICSI. It's designed for women who have been told they have a low egg supply and are looking for options to increase their chances.
This study looks at how certain molecules in your body affect IVF success. It may help doctors understand why some women with low ovarian reserve have better outcomes, and could lead to more personalized fertility treatment.
This study tests a new way to give a fertility hormone (FSH) in pulses through a small tube to see if it helps women with obesity or low egg reserve have better egg development with fewer health risks. It may improve fertility treatment outcomes for these women.
Hear when a new Diminished Ovarian Reserve trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.